Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: Effect on intrahepatic-viral DNA, RNA, and protein expression

Hepatology

Volumn 24, Issue 4 I, 1996, Pages 766-773

  Luscombe, Carolyn ^a,c   Pedersen, John ^b   Uren, Elizabeth ^a   Locarnini, Stephen ^a  

^a FAIRFIELD HOSPITAL   (Australia)

^b MELBOURNE PATHOLOGY   (Australia)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGENITAL INFECTION; CONTROLLED STUDY; DRUG EFFICACY; DUCK; HEPATITIS B; HEPATITIS B VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS REPLICATION;

EID: 0029786431     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008855174     Document Type: Article

References (27)

1. Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heatcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen positive chronic hepatitis G: a meta-analysis. Ann Intern Med 1993;119: 312-323.
2. Hoofnagle JH, Peters M, Mullen KD, Jones DB, Rustgi V, Di-Bisceglie AM, Hallahan C, et al. Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. Gastroenterology 1988;95:1318-1325.
3. Guarascio P, De Felici AP, Migliorini ID, Alexander GJM, Fagan EA, Visco G. Treatment of chronic HBeAg positive hepatitis with acyclovir: a controlled trial. J Hepatol 1986;3(suppl 2):S143-S147.
4. Thomas HC, Karayiannis P, Brook G. Treatment of hepatitis B virus infection with interferon: factors predicting response to interferon. J Hepatol 1991;13(suppl 1):S4-S7.
5. Lee B, Luo W, Suzuki S, Robins MJ, Tyrrell DLJ. In vitro and in vivo comparison of the abilities of purine and pyrimidine 2′,3′-dideoxynucleosides to inhibit duck hepadnavirus. Antimicrob Agents Chemother 1989; 33:336-339.
6. Locarnini SA, Guo K, Lucas CR, Gust ID. Inhibition of HBV DNA replication by ganciclovir in patients with AIDS. Lancet 1989;2:1225-1226.
7. Weller IVD, Carreno V, Fowler MJ, Mojardino J, Marinen D, Varghese Z, Sweney P, et al. Acyclovir in hepatitis B antigen positive chronic liver disease: inhibition of viral replication and transient renal impairment with IV bolus administration. J Antimicrob Chemother 1983;11:223-231.
8. Luscombe C, Pedersen J, Bowden S, Locarnini S. Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapy. Liver 1994;14:182-192.
9. Angus P, Richards M, Bowden S, Ireton J, Sinclair R, Jones R, Locarnini S. Combination antiviral therapy controls severe post-liver transplant recurrence of hepatitis B virus infection. J Gastroenterol Hepatol 1993;8: 353-357.
10. Wang Y, Bowden DS, Shaw T, Civitico G, Chan Y, Qiao M, Locarnini S. Inhibition of duck hepatitis B virus replication in vivo by the nucleoside analogue ganciclovir (9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine). Antiviral Chem Chemother 1991;2:107-114.
11. Lin E, Luscombe C, Wang YY, Shaw T, Locarnini S. The guanosine nucleoside analogue penciclovir is active against chronic duck hepatitis B virus infection in vivo. Antimicrob Agents Chemother 1996 40:413-418.
12. Civitico G, Wang Y, Luscombe C, Bishop N, Tachedjian G, Gust ID, Locarnini S. Antiviral strategies in chronic HBV infection. II. Inhibition of duck hepatitis B virus in vitro using conventional antiviral agents and supercoiled-DNA active compounds. J Med Virol 1990;31:90-97.
13. Dixon R, Jones NF, Freiman JS. Reduced duck hepatitis B virus viraemia in ducklings coinfected with the immunodepressive reticulendotheliosis virus. J Med Virol 1990;30:169-173.
14. Jilbert AR, Freiman JS, Burrell CJ, Holmes M, Gowans EJ, Rowland R, Hall P, et al. Virus-liver cell interactions in duck hepatitis B virus infection - a study of virus dissemination within the liver. Gastroenterology 1988;95:1375-1382.
15. Wu T-T, Coates L, Aldrich CE, Summers J, Mason WS. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 1990;175:255-261.
16. Sambrook J, Fritsch EF, Maniatis T, Nolan C, ed.: Molecular cloning: A laboratory manual. Cold Spring Harbor, NY; Cold Spring Harbor Laboratory 1989.
17. Wang Y, Luscombe C, Bowden S, Shaw T, Locarnini S. Inhibition of duck hepatitis B virus DNA replication by antiviral chemotherapy with ganciclovir-nalidixic acid. Antimicrob Agents Chemother 1995;14:329-340.
18. Fan-Havard P, Nahata MC, Brady MT. Ganciclovir: a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections. J Clin Pharm Ther 1989;14:329-340.
19. Qiao M, Gowans EJ, Bialy SE, Jilbert AR, Burrell CJ. Serological analysis of duck hepatitis B virus infection. Virus Res 1990;17:3-14.
20. Chisari FV, Filippi P, Buras J, McLachlan A, Popper H, Pinkert CA, Palmiter RD, et al. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci U S A 1987;84:6909-6913.
21. Mason WS, Cullen J, Saputelli J, Wu T-T, Liu C, London WT, Lustbader E, et al. Characterization of the antiviral effects of 2′-carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus. HEPATOLOGY 1994;19:393-411.
22. Civitico G, Locarnini S. The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures. Virology 1994; 203:81-89.
23. Tuttleman J, Pourcel C, Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986;47:451-460.
24. Newbold JE, Xin H, Tencza M, Sherman G, Dean J, Bowden DS, Locarnini S. The covalently closed duplex form of the hepadnaviral genome exists in situ as an heterogeneous population of viral minichromosomes. J Virol 1995;69:3350-3357.
25. Delladetsima JK, Vafiadsi I, Tassopoulas NC, Kyriakou V, Apostolaki A, Smyrnoff T. HBcAg and HBsAg expression in ductular cells in chronic hepatitis B. Liver 1994;14:71-75.
26. Blum HE, Stowring L, Figus A, Montgomery CK, Haase AT, Vyas GN. Detection of hepatitis B virus DNA in hepatocytes, bile duct epithelium and vascular elements by in situ hybridization. Proc Natl Acad Sci USA 1983;80:6685-6688.
27. Gish RG, Lau JYN, Brooks L, Fang JWS, Steady SL, Imperial JC, Garcia-Kennedy R, et al. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. HEPATOLOGY 1996;23:1-7.